Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04122222Completed
Open-label trial of influenza vaccine in influenza, sponsored by Mahidol University. Primary endpoint: Antibody titers determined by hemagglutination inhibition assay at 12 months. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04122222.